骨螺紫及其铜配合物与人血清白蛋白相互作用的光谱学研究

采用荧光光谱法、紫外光谱法和傅里叶红外光谱法(FTIR)研究了模拟生理条件下人血清白蛋白(HSA)与骨螺紫(Mx)及其铜配合物(Mx-Cu²⁺)的相互作用. 根据荧光猝灭数据, 二元体系与三元体系中的作用机制均为静态猝灭, 在Cu²⁺存在下, HSA与Mx之间的结合常数与结合位点数明显加大, 结合两个体系的紫外吸收光谱可知, 在三元体系中, Cu²⁺与Mx形成配合物后再与HSA发生作用; 根据Förster能量转移理论, 求得Mx及Mx-Cu²⁺与HSA上氨基酸残基间的距离分别为r=2.82 nm和r=2.53 nm, 三元体系能量转移效率E′大于二元体系E, 说明Cu²⁺在结合作用中可能起到了能量转移介质的作用; 对Δλ=60 nm时的同步荧光光谱的分析表明, 在Mx及Mx-Cu²⁺作用下, HSA色氨酸残基的微区构象发生了变化, 色氨酸残基所处环境的极性增加; 运用FTIR技术定量测定了HSA与Mx及Mx-Cu²⁺作用后二级结构的变化, 发现2个体系中HSA二级结构变化情况基本一致, α-螺旋结构明显减少约8%, β-折叠也减少约1%, 而β-转角和无规卷曲分别增加了约6%和4%. 说明对HSA二级结构造成影响的主要因素是Mx, 它与HSA的结合使蛋白质分子中的肽链部分展开, 二级结构从α-螺旋和β-折叠向β-转角和无规卷曲结构转变, 分子结构的松散程度增加.     

La(Ⅲ)与HSA或BSA的结合平衡研究

用平衡透析法详细研究了pH=6.3条件下La(Ⅲ)与HSA或BSA的结合平衡.Scatchard图分析表明,La(Ⅲ)在HSA中有2个强结合部位和8个弱结合部位;在BSA中有2个强结合部位和6个弱结合部位.从La(Ⅲ)与Cu(Ⅱ),Zn(Ⅱ)和Cd(Ⅱ)等的竞争结合HSA或BSA的结果推测:La(Ⅲ)在HSA或BSA中的一个强结合部位的配位原子可能全部是氧原子.通过非线性最小二乘法拟合Bjerrum方程,首次报道了La(Ⅲ)-HSA和La(Ⅲ)-BSA体系的逐级稳定常数值,其K₁的数量级为10⁴.Hill系数及自由能偶合分析表明La(Ⅲ)与HSA或BSA的结合均产生一定的负协同效应.     

芘与人血清白蛋白和牛血清白蛋白结合位点微环境极性的差异

利用芘(Pyr)的微环境极性探针性质, 采用稳态荧光光谱、 荧光共振能量转移技术结合分子对接法, 对比分析了Pyr分别与人血清白蛋白(HSA)和牛血清白蛋白(BSA)作用机制的差异. 结果表明, HSA和BSA中Pyr的I₁/I₃平均值分别为1.36和0.92; Pyr与HSA和BSA的结合常数分别为1.86×10⁷和1.71×10⁵ L/mol; Pyr与HSA和BSA中色氨酸残基表观距离分别为2.37和2.34 nm. Pyr在HSA和BSA中不同的结合位点位于ⅠB子域和ⅠA子域, 其结合位点周围氨基酸残基的极性是影响Pyr I₁/I₃值的主要原因之一. 实验证实Pyr与HSA和BSA结合作用位点处的微环境极性存在差异.     

基于铽-沙拉沙星配合物的荧光增强测定人血清白蛋白

Tb3+和沙拉沙星(SRFX)反应生成二元配合物,发射Tb3+的特征荧光。人血清白蛋白(HSA)能够增强Tb3+-SRFX配合物的荧光强度,据此,建立了荧光法测定HSA的新方法。在最佳测定条件下,当HSA的浓度在0.50～90.0 mg/L时,Tb3+-SRFX-HSA体系荧光强度的增强和HSA的浓度有良好的线性关系,方法的检出限为0.13 mg/L。用该方法测定了人血清中HSA的含量,回收率在99.2%～99.6%之间。同时对荧光强度增强的机理进行了探讨。     

长春新碱与人血清白蛋白的相互作用研究

利用荧光和圆二色光谱研究了长春新碱(VCR)与人血清白蛋白(HSA)之间的相互作用. 通过荧光猝灭测得在288, 298和308 K时, VCR与HSA的结合常数K分别为2.14×10⁴, 1.73×10⁴ 和1.35×10⁴ L•mol^－1, 表明VCR与HSA间具有较强的结合作用, 属于静态猝灭. 计算出焓变(ΔH)为 －17.38 kJ•mol^－1, 熵变(ΔS)为22.62 J•mol^－1•K^－1, 结合分子模型理论计算的结果, 表明VCR与HSA相互作用时在色氨酸(Trp) 214残基和VCR分子中吲哚基间作用力以疏水作用力为主, 但在 VCR和HSA 分子间以静电引力为主. 圆二色光谱(CD)的数据表明相互作用后HSA的二级结构发生了改变：HSA的α-螺旋的含量从51.7%下降到32.9%, β-折叠的含量增加了9.2%.     

酸性溶液中Fe2+ /Fe3+相互转换对电极还原行为的影响

采用线性扫描伏安法和循环伏安法研究了含有Cl^-、SO₄^2-的酸性溶液中Fe²⁺/Fe³⁺相互转换对电极反应和Fe³⁺还原过程的影响. 结果表明: [Fe]_T=1 mol·L-1条件下,溶液中Fe³⁺/Fe²⁺的还原析出过程经过两个阶段：(1) E=0.35 V左右Fe³⁺还原成Fe²⁺过程; (2) E=-0.3 V之后H+的还原同时Fe²⁺离子与OH^-相结合生产Fe(OH)₂; Fe³⁺/Fe²⁺的相互转化主要影响Fe³⁺的第一还原阶段的还原峰电流和峰电位. |ipa/ipc|值随c(Fe³⁺ )/c(Fe²⁺ )增大而增大,且扫描速度慢时影响大,扫描速度快时影响小; 0.50 mol·L^-1 Fe²⁺+0.50 mol·L^-1 Fe³⁺时,随扫描速率的变化|ipa/ipc|值变化最小(|i_pa/i_pc|≈1.20). 同时,c(Fe³⁺ )/c(Fe²⁺ )也影响平衡电位,平衡电位随c(Fe³⁺ )/c(Fe²⁺ )增大而正移,电位从E₁=0.501 V升至E₅=0.565 V.     

分子光谱法研究美他环素与人血清白蛋白的相互作用

用荧光、紫外等分子光谱法研究了美他环素(MC)与人血清白蛋白(HSA)的相互作用,考察了不同温度下MC与HSA的结合常数KA和结合位点数n,同时研究了Cu2+,Al3+,Pb2+,Ca2+和K+等金属离子对MC与HSA的结合性质的影响.基于F rster偶极-偶极非辐射能量转移机理确定了荧光给体HSA与受体MC间的结合距离.     

六硼化镧和六硼化铈与二氧化碳在高温下的作用

用热重法结合化学分析及X射线等固相鉴定的方法研究了LaB₆和CeB₆与CO₂在500—1000℃范围内的化学作用,实验表明六硼化物于700℃以下在CO₂中比较稳定,而700℃以上作用就渐为显著.在所研究的温度范围内,主要的反应可以式(1)表示:2LnB₆+21CO₂→Ln₂O₃·3B₂O₃+3B₂O₃+21CO(1) 其中Ln=La或Ce;少量的反应按式(2)进行 4LnBe₆+21CO₂→2Ln₂O₃·3B₂O₃+6B₂O₃+21C(2) 根据试样在反应过程中的增重按主要反应式(1)估算了各温度下的反应速度.计算结果表明,当作用量不太大时(即温度不高、或温度虽高而在反应初始阶段),作用分数R与时间t符合于式(3):1-(1-R)^1/3=k₁t(3) 而在较高温度反应进行一定时间后,R与t则有下列关系:[1-(1-R)^1/3]³=k₂t(4) 其中k₁及K₂在不同温度下为不同的常数.对上述结果提出了解释.     

稀土离子跨人血红细胞膜的荧光法研究

采用Fura-2荧光浓度指示剂对红细胞的稀土跨膜作用进行了系列研究.结果表明,稀土离子不能通过完整的红细胞膜进入细胞内.通过与离子载体实验相对照,发现细胞ATP耗竭后,低浓度的稀土离子(5×10^-6mol/L)不能跨膜进入ATP-耗竭红细胞.KCl去极化及加入电压依赖性钙通道刺激剂Bay-K8644对稀土离子的跨膜也没有促进作用.在Ca²⁺内流正常的情况下,低浓度稀土离子(5×10^-6mol/L)对钙离子内流无影响.增大稀土离子浓度到5×10^-4mol/L,用显微镜观察此时红细胞已开始溶血.在模拟胞内离子组分的缓冲液中(pH=7.05),比较了La³⁺,Eu³⁺和Ca²⁺对Fura-2的敏感程度.此条件下Fura-2对La³⁺和Eu³⁺的检测限分别为10-12和10-14mol/L,对Ca²⁺的检测限为10-8mol/L,并测得Fura-2-La³⁺(Eu³⁺)的络合比为1∶1,表观离解常数为1.7×10^-12和4.95×10^-14mol/L,表明用此法检测稀土离子跨膜行为相当灵敏有效.     

Co(phen)2TATP3+与DNA在旋转金盘金环电极上的相互作用研究

在pH=7.2的Tris缓冲溶液中,利用旋转环盘电极法研究了金电极上Co(phen)₂TATP³⁺与DNA的相互作用,并根据扩散控制和电化学控制下得到的各种参数,对它们作用的模式进行了讨论.发现当一定量的DNA存在时,Co(phen)₂TATP³⁺的扩散系数、还原反应的传递系数和半波电位下的速率常数、还原产物Co(phen)₂TATP²⁺的收集系数和脱出率等都发生了较大幅度的减小.利用Co(bpy)₃³⁺进行比较研究表明,Co(phen)₂TATP³⁺与Co(bpy)₃³⁺在加入DNA后在收集系数和传递系数变化上存在较大的差异.     

A novel adsorbent for protein chromatography: supermacroporous monolithic cryogel embedded with Cu2+-attached sporopollenin particles

The aim of this study is to prepare supermacroporous cryogels embedded with Cu(2+)-attached sporopollenin particles (Cu(2+)-ASP) having large surface area for high protein adsorption capacity. Supermacroporous poly(2-hydroxyethyl methacrylate) (PHEMA)-based monolithic cryogel column embedded with Cu(2+)-ASP was prepared by radical cryo-copolymerization of 2-hydroxyethyl methacrylate (HEMA) with N,N'-methylene-bis-acrylamide (MBAAm) as cross-linker directly in a plastic syringe for affinity purification of human serum albumin (HSA). Firstly, Cu(2+) ions were attached to sporopollenin particles (SP), then the supermacroporous PHEMA cryogel with embedded Cu(2+)-ASP was produced by free radical polymerization using N,N,N',N'-tetramethylene diamine (TEMED) and ammonium persulfate (APS) as initiator/activator pair in an ice bath. Embedded particles (10 mg) in PHEMA-based cryogel column were used in the adsorption/desorption of HSA from aqueous solutions. Optimum conditions of adsorption experiments were performed at pH 8.0 phosphate buffer, with flow rate of 0.5 mL/min, and at 5°C. The maximum amount of HSA adsorption from aqueous solution was very high (677.4 mg/g SP) with initial concentration 6 mg/mL. It was observed that HSA could be repeatedly adsorbed and desorbed to the embedded Cu(2+)-ASP in PHEMA cryogel without significant loss of adsorption capacity.     

Interaction of VO2+ ion and some insulin-enhancing compounds with immunoglobulin G

Complexation of VO(2+) ion with the most abundant class of human immunoglobulins, immunoglobulin G (IgG), was studied using EPR spectroscopy. Differently from the data in the literature which report no interaction of IgG with vanadium, in the binary system VO(2+)/IgG at least three sites with comparable strength were revealed. These sites, named 1, 2, and 3, seem to be not specific, and the most probable candidates for metal ion coordination are histidine-N, aspartate-O or glutamate-O, and serinate-O or threoninate-O. The mean value for the association constant of (VO)(x)IgG, with x = 3-4, is log β = 10.3 ± 1.0. Examination of the ternary systems formed by VO(2+) with IgG and human serum transferrin (hTf) and human serum albumin (HSA) allows one to find that the order of complexing strength is hTf ? HSA ≈ IgG. The behavior of the ternary systems with IgG and one insulin-enhancing agent, like [VO(6-mepic)(2)], cis-[VO(pic)(2)(H(2)O)], [VO(acac)(2)], and [VO(dhp)(2)], where 6-mepic, pic, acac, and dhp indicate the deprotonated forms of 6-methylpicolinic and picolinic acids, acetylacetone, and 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone, is very similar to the corresponding systems with albumin. In particular, at the physiological pH value, VO(6-mepic)(IgG)(OH), cis-VO(pic)(2)(IgG), and cis-VO(dhp)(2)(IgG) are formed. In such species, IgG coordinates nonspecifically VO(2+) through an imidazole-N belonging to a histidine residue exposed on the protein surface. For cis-VO(dhp)(2)(IgG), log β is 25.6 ± 0.6, comparable with that of the analogous species cis-VO(dhp)(2)(HSA) and cis-VO(dhp)(2)(hTf). Finally, with these new values of log β, the predicted percent distribution of an insulin-enhancing VO(2+) agent between the high molecular mass (hTf, HSA, and IgG) and low molecular mass (lactate) components of the blood serum at physiological conditions is calculated.     

Drug-human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detection

A new technique for investigating drug-protein binding was developed employing capillary electrophoresis (CE) coupled with tris(2,2'-bipyridyl) ruthenium(II) [Ru(bpy)(3) (2+)] electrochemiluminescence (ECL) (CE-ECL) detection after equilibrium dialysis. Three basic drugs, namely pridinol, procyclidine and its analogue trihexyphenidyl, were successfully separated by capillary zone electrophoresis with end-column Ru(bpy)(3) (2+) ECL detection. The relative drug binding to human serum albumin (HSA) for each single drug as well as for the three drugs binding simultaneously was calculated. It was found that the three antiparkinsonian drugs compete for the same binding site on HSA. This work demonstrated that Ru(bpy)(3) (2+) CE-ECL can be a suitable technique for studying drug-protein binding.     

A highly sensitive assay for protein with dibromochloro-arsenazo-Al(3+) using resonance light scattering technique and its application

A simple, sensitive and selective method has been developed for the determination of protein using resonance light scattering (RLS) technique. The method is based on the interaction of protein and arsenazo-DBC-Al(3+) in the pH range of 5.0-7.0, which causes a substantial enhancement of the resonance scattering signal of arsenazo-DBC-Al(3+) in the wavelength range of 300-550 nm with the maximum RLS platform at 405-420 nm. With this method, 2.50-50.00 mug ml(-1) of bovine serum albumin (BSA) and 2.50-60.00 mug ml(-1) of human serum albumin (HSA) can be determined, and the detection limits, calculated three times the standard deviation (S.D.) of six blank measurements, for BSA and HSA were 123.4 and 89.6 ng ml(-1), respectively. Moreover, the method is free from interference from many amino acids and metal ions. The method, with high sensitivity, selectivity and reproducibility, was satisfactorily applied to the determination of total protein in human serum samples. Mechanism studies indicated that arsenazo-DBC-Al(3+) could bind to BSA depending mainly on electrostatic forces, which results in enhanced RLS in the arsenazo-DBC-Al(3+)-protein system.     

Study on the enhancement of Ru(bpy)3(2+) electrochemiluminescence by nanogold and its application for pentoxyverine detection

In this work, CE separation with end-column Ru(bpy)3(2+) ECL detection for the quantitative determination of pentoxyverine was firstly performed. The experimental conditions, such as the applied potential, injection voltage, injection time, and the pH of separation buffer, were discussed in detail. Gold nanoparticles were found to enhance the ECL intensity at an appropriate volume ratio of nanogold with Ru(bpy)3(2+) but without changing their nanoproperties proved by transmission electron microscopy (TEM) and UV-vis spectra. The detection limits with or without nanogold were 6 nM and 0.6 microM, respectively. Successful separation of pentoxyverine, chlorpheniramine, and lidocaine was achieved. This method was also applied to monitor drug binding with HSA, and the binding constant for pentoxyverine was estimated as 1.8 x 10(3)/M.     

Synthesis and physicochemical characterization of new squalenoyl amphiphilic gadolinium complexes as nanoparticle contrast agents

A family of novel amphiphilic gadolinium chelates was successfully obtained by coupling the hydrophilic DOTA ligand [1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane] to squalenoyl moieties. Thanks to the self-assembling properties of their squalenoyl lipophilic moieties, all these derivatives were able to form, without any adjuvant, micellar or liposome-like supramolecular nanoassemblies, endowed with high relaxivities (r(1) = 15-22 mM(-1) s(-1) at 20 MHz and 37 °C). The remarkably high payloads of Gd(3+) ions reached 10 to 17 wt %. Moreover, one of these derivatives interacted with human serum albumin (HSA) forming mixed micelles, which induced a remarkable increase in relaxivity. Liposome-like structures were obtained when the Gd(3+) complex of DOTA was coupled to two squalene units. These liposomal structures were characterized by a high loading of Gd(3+) (about 74,000 gadolinium ions per particle of 100 nm). The supramolecular architecture of these nano-objects has been investigated by electron microscopy and small-angle X-ray scattering. Squalenoylation of gadolinium derivatives offers a platform to conceive contrast agents (CAs) in mild conditions (no toxic solvents, no surfactants, no energy input). These new amphiphilic gadolinium chelates could also find potential applications in theranostics, by forming mixed systems with other squalenoylated drugs, or to delineate blood vessels owing to the interaction with HSA.     

Fluorimetric study of the interaction between human serum albumin and quinolones-terbium complex and its application

A highly sensitive spectrofluorimetric method is proposed for determination of human serum albumin (HSA) and some quinolone drugs. Using quinolones-terbium (Tb3+) complex as a fluorescent probe, in the buffer solution of pH 7.8, HSA can remarkably enhance the fluorescence intensity of the quinolones-Tb3+ complex at 545 nm and the enhanced fluorescence intensity of Tb3+ ion is in proportion to the concentration of HSA and quinolone drugs. Optimum conditions for the determination of HSA were also investigated. The linear ranges and limits of detection are 8.0 x 10(-9) to 8.0 x 10(-8) mol L(-1), 4.20 x 10(-9) mol L(-1) (for HSA); 1.0 x 10(-6) to 4.0 x 10(-6) mol L(-1), 1.87 x 10(-8) mol L(-1) (for norfloxacin) and 1.0 x 10(-7) to 1.0 x 10(-6) mol L(-1), 4.82 x 10(-8) mol L(-1) (for enoxacine), respectively. This method is simple, practical and relatively free interference from coexisting substances, as well as much more sensitive than most of the existing assays.     

1H and (113)Cd NMR Investigations of Cd(2+) and Zn(2+) Binding Sites on Serum Albumin: Competition with Ca(2+), Ni(2+), Cu(2+), and Zn(2+)

1H and (113)Cd NMR studies are used to investigate the Cd(2+) binding sites on serum albumin (67 kDa) in competition with other metal ions. A wide range of mammalian serum albumins possess two similar strong Cd(2+) binding sites (site A 113-124 ppm; site B 24-28 ppm). The two strong sites are shown not to involve the free thiol at Cys34. Ca(2+) influences the binding of Cd(2+) to isolated human albumin, and similar effects due to endogenous Ca(2+) are observed for intact human blood serum. (1)H NMR studies show that the same two His residues of human serum albumin are perturbed by Zn(2+) and Cd(2+) binding alike. Zn(2+) displaces Cd(2+) from site A which leads to Cd(2+) occupation of a third site (C, 45 ppm). The N-terminus of HSA is not the locus of the two strong Cd(2+) binding sites, in contrast to Cu(2+) and Ni(2+). After saturation of the N-terminal binding site, Cu(2+) or Ni(2+) also displaces Cd(2+) from site A to site C. The effect of pH on Cd(2+) binding is described. A common Cd(2+)/Zn(2+) binding site (site A) involving interdomain His residues is discussed.     

Specific determination of unbound oxacillin in protein solution with cefoperazone by high-performance frontal analysis with chemiluminescence detection

Unbound oxacillin concentrations in human serum albumin (HSA) solutions in the presence or absence of cefoperazone were determined using high-performance frontal analysis coupled with chemiluminescence detection (HPFA-CL). The HPFA was performed on an ISRP column with 67 mM potassium phosphate buffer of pH 7.4 and ionic strength of 0.17 as the mobile phase. The luminol-H(2)O(2)-Co(2+) system was employed in the chemiluminescence detection. The detection was highly specific for oxacillin in the presence of cefoperazone. Although both drugs in HSA solutions co-eluted in the same region in HPFA, cefoperazone did not interfere with the determination of unbound concentration of oxacillin. In the solution of 100 microM HSA and 11.33 micro M oxacillin the bound percentage of oxacillin to HSA was estimated as 80.5%. Addition of 30.98 micro M cefoperazone into the HSA-equilibrated solution produced little effect on the protein binding of oxacillin. In the presence of 154.9 micro M cefoperazone, however, the bound percentage of oxacillin was significantly reduced. This specific method could be applied to the investigation of drug-drug interaction in protein binding.